Evaluation of cranial nerve mononeuropathy

Last reviewed: 10 Aug 2025
Last updated: 17 May 2022

Summary

Differentials

Common

  • Ischemic optic neuropathy (II)
  • Multiple sclerosis (II)
  • Viral infection (II)
  • Subarachnoid hemorrhage (III, IV, VI)
  • Meningitis (III, IV, VI)
  • Ischemic neuropathy (III, IV, VI)
  • Vascular malformations (V)
  • Herpes zoster (V)
  • Multiple sclerosis (V)
  • Bell palsy (VII)
  • Ramsay Hunt syndrome (VII)
  • Ischemic stroke (VII)
  • Vestibular neuritis (VIII)
  • Neural presbycusis (VIII)
  • Drugs (VIII)
  • Iatrogenic (X)
  • Apical lung tumor (IX, X)
  • Iatrogenic (XI)
  • Ischemic stroke (XII)
Full details

Uncommon

  • Trauma (I)
  • Neurodegenerative disorders (I)
  • Congenital (I)
  • CNS tumors (I)
  • Optic canal trauma (II)
  • CNS tumors (II)
  • Idiopathic intracranial hypertension (II)
  • Autoimmune disease: (e.g., systemic lupus erythematosus (SLE), Sjogren, granulomatosis with polyangiitis, Behcet disease [II])
  • Leber hereditary optic neuropathy (II)
  • Optical toxins or nutritional deficiency (II)
  • Neuromyelitis optica (II)
  • Uncal herniation (III, IV, VI)
  • Migraine (III, IV, VI)
  • Trauma (III, IV, VI)
  • Cerebral aneurysms (III, IV, VI)
  • Cavernous-carotid fistula (III, IV, VI)
  • Cavernous sinus thrombus (III, IV, VI)
  • CNS tumors (III, IV, VI)
  • Drugs (III, IV, VI)
  • Idiopathic intracranial hypertension (III, IV, VI)
  • Congenital (III, IV, VI)
  • Post-lumbar puncture (VI)
  • Meningitis (V)
  • CNS tumors (V)
  • Autoimmune disorders (V)
  • Skull-base osteomyelitis (V)
  • Trauma (V)
  • Dental abscess (V)
  • Spinal cord lesion (V)
  • Iatrogenic (V)
  • Mandibular tumors (V)
  • Congenital (V)
  • Tolosa-Hunt syndrome (V)
  • Wallenberg syndrome (V)
  • Neurosarcoidosis (VII)
  • CNS tumors (VII)
  • Trauma (VII)
  • Meningitis (VII)
  • Iatrogenic (VII)
  • Middle ear or mastoid infection (VII)
  • Parotid tumor (VII)
  • HIV associated (VII)
  • Lyme disease (VII)
  • CNS tumors (VIII)
  • CNS tumors (IX, X)
  • Parapharyngeal tumor (IX, X)
  • Meningitis (IX, X)
  • Skull-base osteomyelitis (IX, X)
  • Trauma (IX, X)
  • Parapharyngeal space infection (IX, X)
  • Eagle syndrome (IX)
  • Cardiovocal syndrome (X)
  • Trauma (XI)
  • CNS tumors (XI)
  • CNS tumors (XII)
  • Progressive bulbar palsy (XII)
  • Chiari I and II malformations (XII)
  • Extracranial (tongue or neck) or skull-base tumors (XII)
  • Meningitis (XII)
  • Skull-base osteomyelitis (XII)
  • Parapharyngeal space infection (XII)
  • Trauma (XII)
  • Dural arteriovenous fistula (XII)
  • Internal carotid artery aneurysm or dissection (XII)
  • Iatrogenic (XII)
Full details

Contributors

Authors

Ann Johnston, MB BS, MRCP

Consultant Neurologist

Department of Neurology

University Hospital of Wales

Cardiff

UK

Disclosures

AJ has received speaker fees from UCB and Eisai for lectures given.

Emma Tallantyre, BMBS, PhD

Neurology Specialist Registrar

University Hospital of Wales

Cardiff

UK

Disclosures

ET has received honoraria for consulting work from Novartis, Merck, Biogen, and Roche. She has received travel grants to attend or speak at educational meetings from Merck, Roche, Takeda, and Novartis.

Acknowledgements

Dr Johnston and Dr Tallantyre would like to gratefully acknowledge Dr Zachary L. Hickman, Dr Brad E. Zacharia, Dr Christopher J. Winfree, and Dr Adrian J. Wills, the previous contributors to this topic.

Disclosures

ZLH, BEZ, CJW, and AJW declare that they have no competing interests.

Peer reviewers

Robert L. Ruff, MD, PhD

Professor of Neurology

Department of Neurology

Cleveland VA Medical Center

Cleveland

OH

Disclosures

RLR declares that he has no competing interests.

Sabrina Ravaglia, MD, PhD

Staff Physician

Department of Neurological Sciences

Institute of Neurology C. Mondino

Pavia

Italy

Disclosures

SR declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Richards BW, Jones FR Jr, Younge BR. Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol. 1992;113:489-496. Abstract

Erman AB, Kejner AE, Hogikyan ND, et al. Disorders of cranial nerves IX and X. Semin Neurol. 2009;29:85-92. Abstract

Afifi AK, Bergman RA. Functional neuroanatomy: text and atlas. 2nd ed. New York, NY: McGraw-Hill; 2005.

Newman NJ, Dickersin K, Kaufman D, et al. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996;114:1366-1374. Abstract

Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109:1673-1678. Abstract

Ayberk G, Özveren MF, Yildirim T, et al. Review of a series with abducens nerve palsy. Turk Neurosurg. 2008;18:366-373.Full text  Abstract

Jacobson DM, Trobe JD. The emerging role of magnetic resonance angiography in the management of patients with third cranial nerve palsy. Am J Ophthalmol. 1999;128:94-96. Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Use of this content is subject to our disclaimer